133750 — MegaMD Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapContrarian

Annual income statement for MegaMD Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	80,374	82,440	79,435	64,468	36,041
Cost of Revenue
Gross Profit	48,601	50,814	48,891	39,002	20,034
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	81,219	76,186	74,620	62,601	41,275
Operating Profit	-845	6,253	4,815	1,867	-5,233
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,607	7,268	7,935	2,641	-3,177
Provision for Income Taxes
Net Income After Taxes	805	4,885	6,650	2,113	-3,197
Minority Interest
Net Income Before Extraordinary Items
Net Income	413	4,897	6,650	2,113	-3,197
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	413	4,897	6,650	2,113	-3,197
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.29	256	411	116	-93.5
Dividends per Share